Brief: Royalty Pharma To Acquire Royalty Interest In Geron’S RYTELO For $125 Mln
07/11/2024 12:13
Nov 7 (Reuters) - Geron Corp GERN.O :
* ROYALTY PHARMA TO ACQUIRE ROYALTY INTEREST IN GERON’S
RYTELO FOR
$125 MILLION
* ROYALTY PHARMA PLC -DEAL INCREASES SYNTHETIC ROYALTY
FUNDING TO
$925 MILLION IN 2024
Source text: ID:nGNXs5fdM
Further company coverage: GERN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Royalty Pharma
See all newsAnalysis: Revolution Medicines' Europe efforts signal solo launch ambitions for cancer drug
U.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple
Royalty Pharma falls after Novartis' cholesterol drug fails in study
Brief: Royalty Pharma Announces Update On Novartis’ Phase 3 Topline Results For Pelacarsen
Teva's immune disorder drug meets main goal in mid-stage trial (updated)